Our Experts
Work with Industry Thought Leaders at Every Stage of Your Clinical Research Study
With so much at stake, you want the best minds focused on your clinical trial. ERG delivers, with teams of experts working on every facet.
Nitendra Agarwal, MD
Internal Medicine
Glen Apseloff, MD
Abuse Liability/Clin Pharm
Sarah Atkinson, MD
Psychiatry Adult/Pediatric
Alina Beaton, MD
Internal Medicine/Pain
Mark Brody, MD
Neurology/AD
Keith Candiotti, MD
Anesthesiology/Pain
Andria Chastain
Psychiatry/Addiction
Andrew Cutler, MD
Psychiatry/Neurology/Addiction
Clay Dehn
Metabolism/NASH/Clin Pharm
Emanuel DeNoia, MD
Phase 1/Internal Medicine
Stacy Dilzer
Clin Pharm/Renal/Hepatic
Bernadette D’Souza, MD
Psychiatry/Addiction
Judith Dunn, PhD
Drug Development/CNS
Ana Fuquay
Alzheimer’s Disease/Neurology
Grant Garbo, MD
Emergency Medicine
Daniel Gruener, MD
Psychiatry/Pain/Addiction
M. Saleem Ismail, MD
AD/Psychiatry/Geriatric Psychiatry
George Konis, MD
Psychiatry/Addiction/Internal Medicine
Luke Kramer
Patient Advocate
David Leiman, MD
Acute & Chronic Pain/Anesthesiology
Suresh Mallikaarjun, MD
Drug Development/Clin Pharm
William Martin, PhD
Drug Development/CNS
Harold Minkowitz, MD
Acute & Chronic Pain/Anesthesiology
Ashley Poole
Psychiatry/Pediatric
Miranda Porter, PhD
Psychiatry/Neuropsychology
Alexander Prezioso, MD
Obstetrics & Gynecology/Phase 1
Denise Roberts
Pain/NASH/ General Medical
Steve Romano, MD
Drug Development/CNS
Janeen Rosales
Phase 1/Special Populations
Dennis Ruff, MD
Phase 1/Internal Medicine
Sherwyn Schwartz, MD
Endocrinology/NASH
Neil Singla, MD
Acute & Chronic Pain/Anesthesiology
Stephen Thein, PhD
Sleep/AD
Erin Tireman, PsyD
CNS Rater Training, Psychedelics
Daniel Umbricht, MD
Translational Medicines/CNS
Kimberly Vanover, PhD
Drug Development/CNS
Richard Walovitch, MD
Imaging/Pharmacology
Lori Wright
Psychiatry
Dr. William Martin
Drug Development/CNS
Dr. Daniel Gruener
Psychiatry/ Pain/Addiction
Dr. Sarah Atkinson
Psychiatry Adult/Pediatric
Dr. Mark Brody
Neurology/AD
Dr. Stephen Thein
Sleep/AD
Dr. Suresh Mallikarjun
Drug Development/Clin Pharm
Glen Apseloff, MD
Clinical Pharmacology / Human Abuse Potential
- Founder and Investigator of Ohio Clinical Trials
- Board Certified in Clinical Pharmacology
- Holds degrees from Massachusetts Institute of Technology (MIT) and Ohio State University College of Medicine
- Held numerous teaching positions in clinical pharmacology
- On the editorial board of 3 peer review journals
- 30+ years of clinical research experience
- Participated in hundreds of studies
- Authored over a hundred abstracts and publications
- Hold two patents
Dr. Steve Romano
Drug Development/CNS
Dr. David Leiman
Acute and Chronic Pain
Dr. Harold Minkowitz
Chronic Pain
Andria Chastain
Psychiatry/Addiction
Denise Roberts
Pain/NASH/General Medical
Dr. Kimberly Vanover
Drug Development/CNS
Dr. Andrew Cutler
Psychiatry/ Neurology/Addiction
Dr. Judith Dunn
Drug Development/CNS
Dr. Daniel Umbricht
Translational Medicine/CNS
Dr. Bernadette D’Souza
Psychiatry/Addiction
Dr. Sherwyn Schwartz
Diabetes/NASH
Dr. Paul Michael Ramirez
Ratings Expert, Rater Training
Clayton Dehn
Metabolism/NASH/Clin Pharm
- Vice President of Clinical Pharmacology Services at Evolution Research Group
- Published in numerous peer-reviewed journal articles
- Conducted 160+ Phase I-IV clinical trials with challenging population inclusive of Diabetes, Vulvovaginal Candidiasis, Healthy Volunteers, Hypogonadal, Liver Disease, Coronary Artery Disease, NASH, Postpartum Depression, Alzheimer’s, and many other medical as well as psychiatric indications
- Commissioner of the Arizona Biomedical Research Commission, Editor-In-Chief of Series of Endocrinology Diabetes and Metabolism and Editorial Board Member of various well-established journals
Luke Kramer
Patient Advocate
Janeen Rosales
Phase 1/Special Populations